JNNP podcast
- Website
- http://soundcloud.com/bmjpodcasts/sets/jnnp
- Description
- JNNP's ambition is to publish the most ground-breaking and cutting-edge research from around the world. Encompassing the entire genre of neurological sciences, our focus is on the common disorders (stroke, multiple sclerosis, Parkinson's disease, epilepsy, peripheral neuropathy, subarachnoid haemorrhage and neuropsychiatry), but with a keen interest in the Gordian knots that present themselves in the field, such as ALS.
- Language
- 🇬🇧 English
- last modified
- 2024-12-15 05:44
- last episode published
- 2024-07-15 11:03
- publication frequency
- 13.2 days
- Contributors
- BMJ Group
- Author Owner
- Explicit
- false
- Number of Episodes
- 318
- Rss-Feeds
- Detail page
- Categories
- Medicine Science & Medicine Health & Fitness
Recommendations
Episodes
| Date | Title & Description | Contributors |
|---|---|---|
| 2024-07-15 |
Distinguishing autoimmune nodopathies from CIDP, with Dr. Ruth Huizinga and Dr. Maarten Titulaer Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) can be difficult to distinguish from autoimmune nodopathy. In this podcast, Dr. Saima Chaudhry (1) is joined from the Netherlands by Dr. Ruth Huizinga (2) and Dr. Maarten Titulaer (3), to... |
|
| 2024-04-17 |
Nutritional peripheral neuropathies, with Dr. Alexander Rossor The cause of a nutritional neuropathy may not always be obvious when first examining a patient. Restrictive diets with roots in religious practices or personal preferences will be less familiar to neurologists than issues involving bariatric surgery or... |
|
| 2024-02-19 | How often do movement disorder specialists agree when classifying tics? A recent study published in JNNP explores this question with a two-stage approach, seeking a diagnosis from experts first based on video evidence alone and then following the provi... |
|
| 2023-09-22 | With the UK government announcing plans to make recreational use of nitrous oxide illegal, JNNP podcast host Dr. Saima Chaudhry (1) is joined by London-based neurologist Dr. Alastair Noyce (2)(3) to examine the findings of his group's recently publishe... |
|
| 2023-08-08 | Social media platforms and clinical patient encounters are abundant in references to brain fog, but how much is it really understood? In this episode, JNNP's podcast host, Dr. Saima Chaudhry (1), speaks with Dr. Laura McWhirter (2) about her recently p... |
|
| 2023-06-15 | In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Michael Benatar (2) about his recently published article, "A roadmap to ALS prevention: strategies and priorities". This explores a new approach to Amyotrophic lateral scle... |
|
| 2023-05-15 | In this episode, JNNP's new podcast host Dr. Saima Chaudhry (1) speaks with Dr. Matteo Gastaldi (2) about Myelin oligodendrocyte glycoprotein antibody-associated disease, or MOGAD for short. A multi-centre retrospective study, "Prognostic relevance of ... |
|
| 2021-12-21 |
CGRP in migraine: current therapeutics, future implications and potential off-target effects In this podcast, JNNP's Podcast Editor, Colin Mahoney, interviews Dr Jason Ray (Neurology, Alfred Health, and Department of Neuroscience, Monash University, Melbourne). Dr Ray discusses the role of calcitonin gene related peptide in migraine and the gr... |
|
| 2021-11-17 |
Alemtuzumab's impact on functional and structural integrity of the visual system in MS Prof Michael Barnett, Director Sydney Neuroimaging Analysis Centre and Professor of Neurology, University of Sydney, joins JNNP's Podcast Editor, Colin Mahoney, to discuss how the use of Alemtuzumab may have longer-term impacts on improving one of the ... |
|
| 2021-09-27 |
Guidelines for the management of functional speech and communication disorders A/Prof Jan Baker, Speech Pathologist, Flinders University and UTS. Dr Laura McWhirter, University of Edinburgh joins editor Colin Mahoney to discuss the first comprehensive guidelines developed to assist speech and language professionals in the manag... |
|